Top

Amgen Forced To Suspend Trial Of Promising Cancer Drug

November 20, 2008

Amgen Inc., a unit of Takeda Pharmaceutical Co. has been forced to suspend a late-stage trial of a very promising cancer drug.......Washington (dbTechno) - Amgen Inc., a unit of Takeda Pharmaceutical Co. has been forced to suspend a late-stage trial of a very promising cancer drug.

The experimental drug in question is known as motesanib and was going to be used in combination with other drugs as something that could treat lung cancer.

The other drugs it was designed to work along with include carboplatin, as well as paclitaxel.

Data has shown that those who take the new experimental drug experience higher early mortality rates.

This compared directly to patients who were not on the drug and instead were taking a placebo.

Amgen has immediately pulled the plug and suspended the trial.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists

Comments


All comments are moderated.
If your comment is approved, it will be posted within 24 hours





Breaking News

Panel Votes to Reduce Strength of Painkillers

Boston (DbTechNo) - An advisory panel to the FDA have recommended that the FDA take a closer look into lowering the dosages... 

July 3, 2009 |

Fewer Children Attending Summer Camps Due to Swine Flu

Boston (DbTechNo) - Parents of young children are thinking twice about sending them to summer camps because of swine flu. The... 

July 3, 2009 |

Hacker Develops Jailbreak for iPhone 3GS

Boston (DbTechNo) - The very first iPhone 3GS jailbreak is now available for download thanks to hacker George Hotz. George... 

July 3, 2009 |

Bottom